UBS AM’s Concordia International Corp. Common Stock CXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-39,633
Closed -$85K 2511
2016
Q4
$85K Sell
39,633
-17,259
-30% -$52.8K ﹤0.01% 2268
2016
Q3
$254K Buy
56,892
+29,033
+104% +$364K ﹤0.01% 2349
2016
Q2
$597K Buy
27,859
+10,900
+64% +$287K ﹤0.01% 1873
2016
Q1
$436K Sell
16,959
-1,500
-8% -$44.8K ﹤0.01% 1996
2015
Q4
$751K Buy
18,459
+6,410
+53% +$226K ﹤0.01% 1851
2015
Q3
$512K Sell
12,049
-39,948
-77% -$2.96M ﹤0.01% 2010
2015
Q2
$3.76M Buy
+51,997
New +$3.76M ﹤0.01% 1140

Other funds holding CXRX

UBS AM's CXRX Position: Q1 2017 in Review

UBS AM sold out of Concordia International Corp. Common Stock (CXRX) in Q1 2017, closing a stake of 39,633 shares — an estimated $85K sold.

UBS AM first reported a position in CXRX in Q2 2015 and held it in 7 quarters. The position peaked at $3.76M in Q2 2015. 38 funds tracked by Wall St. Rank hold CXRX as of Q1 2017.

  • UBS AM reported no remaining Concordia International Corp. Common Stock position as of Q1 2017 after selling out during the quarter.
  • UBS AM sold 39,633 Concordia International Corp. Common Stock shares in Q1 2017, an estimated $85K.
  • UBS AM first reported a position in Concordia International Corp. Common Stock in Q2 2015 and held it in 7 quarters.
  • UBS AM's Concordia International Corp. Common Stock position peaked at $3.76M in Q2 2015.
  • 38 funds tracked by Wall St. Rank held Concordia International Corp. Common Stock as of Q1 2017.

Based on UBS AM's 13F filing for Q1 2017, filed 4 May 2017.